References [1] Sawale, M., Desai, A., & Redkar, V
The clinical evidence is clear, the mechanism is understood, and patients report real symptom relief
Mitchell JL, Lyons HS, Walker JK, Yiangou A, Grech O, Alimajstorovic Z, Greig NH, Li Y, Tsermoulas G, Brock K, Mollan SP, Sinclair AJ
In the SCALE Sleep Apnea RCT, liraglutide 3.0 mg was associated with a significant reduction of apnea-hypopnea index (AHI) compared to placebo (6.1 events per hour, 95% 11 to 1.2 events per hour) at 32 weeks in patients with moderate to severe OSA not on positive airway pressure 20
Options include partial reconstitution (if feasible with your vial format), freezing portions of reconstituted solution (accepting some potency loss), or adjusting your dose higher to use everything before expiration
Because BPC-157 is not FDA-approved, it should not be purchased from unverified online sellers or research chemical websites